Key result
This review provides a comprehensive overview of the biological mechanisms, risk factors, diagnosis, and management strategies for bioprosthetic aortic valve degeneration after TAVR and SAVR.
Why the study?
The increasing use of bioprosthetic valves in younger patients has led to a subsequent rise in bioprosthetic aortic valve degeneration after TAVR and SAVR.
No takes yet. Share an insight, caveat, or question.
This review provides a comprehensive overview of the mechanisms, incidence, diagnosis, and management strategies for bioprosthetic aortic valve degeneration after TAVR and SAVR.
Bismee et al. (2024) conducted a review in Bioprosthetic aortic valve degeneration (BAVD). Transcatheter and surgical aortic valve replacement (TAVR and SAVR) was evaluated. This review provides a comprehensive overview of the biological mechanisms, risk factors, diagnosis, and management strategies for bioprosthetic aortic valve degeneration after TAVR and SAVR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: